Spain gives go ahead to research using therapeutic cloning
larger | smaller
By h.b. - Jan 24, 2008 - 7:37 AM
Three research projects have been given permission, two in Valencia and one in Madrid
The Spanish Commission for the Control of the Donation and Use of Human Stem Cells, a body which depends on the Ministry for Health and Consumer Affairs, has given the green light to the first project in Spain which will use the technique known as nucleus transfer. This is therapeutic cloning to obtain lines of stem cells which are prepared specifically from the patient.
The research is led by Miodrag Stojkovic at the Centro Prínciple Felipe de Valencia, and is intended to investigate the molecular bases of two neurological illnesses, child epilepsy and hereditary palsy. Stojkovic was the first European scientist who managed to clone a human embryo from embryonic stem cells.
The Ministry for Health has also given its support to two other studies, one in Valencia and another in Madrid, but the final approval still has to be obtained from the regional governments in each region.
|
|
Click here for related stories |
mobile
|
email this article
|
printer friendly page
del.icio.us
|
digg
|
technorati
|
yahoo
|
Stumble It!
Reddit
|
Newsvine
|
Meneame
|
Wikio
Blink
|
Google
|
Fresqui
|
MSN reporters
|
Live Spaces
My Space
|
Fark
|
Mixx
|
Twitter
Spain News : National
Readers' comments:
Please keep to the subject. Opinions published here are of our visitors, not the Typically Spanish team. Comments which go against Spanish laws or which are libellous are not allowed. We reserve the right to delete any comment we wish. Placing a comment indicates you have read our terms and conditions and privacy policy .
Por favor, céntrate en el tema. Son las opiniones de los internautas, y no las de Typically Spanish. No está permitido verter comentarios contrarios a las leyes españolas o injuriantes. Reservado el derecho a eliminar los comentarios que consideremos fuera de tema. Escribir un comentario indica que has leído nuestros condiciones de uso y politica de privacidad .


RSS


